AKT1 and cancer: GSEA showed that the pathway of PI3K/AKT/mTOR, G2/M checkpoints, and E2F target were abnormally activated in NEIL3 patients while western blot revealed that NEIL3 could partially activate the PI3K/AKT/mTOR signaling pathway, which might be responsible for the cancer-promoting effects of NEIL3.